COVID-19 MAKES IT DOUBLE FOR SEARL
In a very short span of time, M/s SEARL resorts to the next level of distribution agreement with Reckitt Benckiser and gets a go-ahead and rights to manufacture dozens of the big brands which also include the big names like Dettol, Disprin GAVISCON, and BONJELA
The Reckitt Benckiser has observed a growth of 9.3% in the first half of the current financial year, and the CEO of the Company is very optimistic about a sustained growth in the sales of healthcare products because of the COVID-19
Earlier in June 2017, M/s Reckitt Benckiser had acquired Mead Johnson Nutrition Company with a vision and mission of enhancing sales by Rs. 1-2 billion and hoping to get the manufacturing rights for the Big Brands.
It is reliably learnt that SEARL may now be better equipped to cope with the ever expanding business requirement emanating from the other outbreaks like SARS and MERS.
Experts suggest that despite COVID wave may be over in a year or so, but the new normal healthcare practices are likely to continue for a longer period than anticipated. Hence, the sales which surged due COVID may remain in vogue for couple of years.
The reports about the manufacturing facility is in the discussions of the market sources, and the company has not as yet chosen to either confirm or deny the same